MD Anderson Cancer Center sets to begin new "Moon Shost" program in February 2013, targeting 8 specific kinds of cancer including Triple Negative Breast Cancer and Ovarian Cancer which both share similar genetic causes. MD Anderson has committed to spend $3 billion dollars in an effort to finding cures and lower deaths over the next 10 years of breast and ovarian, lung, prostate, melanoma, and 3 types of leukemia
http://www.mdanderson.org/newsroom/news-releases/2012/ut-md-anderson-cancer-center-launches-unprecedented-moon-shots-program.html (Click link for full story)
Breast and ovarian cancer GOALS
- Increase the five-year survival rate of women with triple-negative breast cancer or high-grade serous ovarian cancer
- Identify women and families at risk for these cancers and implement programs to decrease the chance they will develop cancer
- Change the upfront treatment to improve the outcomes of women with these cancers
- Within the first year, implement clinical trials of promising new therapies
- Develop new imaging technologies that can detect aggressive lethal breast tumors at an early stage
- Convert temporary responses to durable therapy by identifying and targeting drug resistance mechanisms